Financial Performance - Revenue for the year ended December 31, 2025, increased to HKD 33,117,000 from HKD 30,151,000, representing a growth of 9.8%[3] - Gross profit rose to HKD 16,233,000, up from HKD 12,416,000, marking a significant increase of 30.5%[3] - The company reported a net loss of HKD 19,993,000 for the year, an improvement from a net loss of HKD 28,882,000 in the previous year, reflecting a reduction of 30.5%[4] - Total revenue for the group increased to HKD 33,117,000 in 2025 from HKD 30,151,000 in 2024, reflecting a growth of about 6.5%[12] - The company reported a pre-tax loss of HKD 29,403,000 for the year 2025, compared to a loss of HKD 34,596,000 in 2024[21][24] - The company’s attributable loss decreased by approximately 83.9% to about HKD 5,500,000 for the year ended December 31, 2025, compared to a loss of HKD 34,600,000 for the year ended December 31, 2024[53] Assets and Liabilities - Total assets increased to HKD 342,068,000 from HKD 311,048,000, showing a growth of 10%[5] - Non-current assets surged to HKD 59,181,000, up from HKD 12,080,000, indicating a substantial increase of 389.5%[5] - The total equity increased to HKD 222,681,000 from HKD 155,421,000, reflecting a growth of 43.3%[6] - The non-current liabilities decreased to approximately HKD 16,600,000 from HKD 25,600,000 in 2024[66] - The capital-to-asset ratio improved to approximately 44.5% from 51.9% in 2024[66] Cash and Financing - The company's cash and bank balances rose to HKD 27,010,000 from HKD 19,548,000, representing a growth of 38.1%[5] - The company’s financing costs rose to HKD 2,010,000 in 2025 from HKD 1,922,000 in 2024, primarily due to increased borrowing costs[20] - The company issued bonds with a face value of HKD 12,000,000 at an interest rate of 6.5%, maturing in 2030[39] Revenue Segments - Revenue from advertising services decreased to HKD 4,765,000 in 2025 from HKD 20,241,000 in 2024, representing a decline of approximately 76.5%[12] - E-commerce business revenue reached HKD 21,451,000 in 2025, with no revenue reported in 2024, indicating a significant growth in this segment[12] - The revenue from advertising and e-commerce services was approximately HKD 26,200,000, accounting for about 79.2% of the total revenue for the group[42] - The total revenue from advertising and e-commerce businesses was approximately HKD 26,200,000, representing an increase of about 29.5% compared to HKD 20,200,000 for the year ending December 31, 2024[50] Operational Changes - The group completed the acquisition of 100% of BFB Development Inc. in 2025, which primarily sells health products through e-commerce channels, leading to a restructuring of its operating segments[16] - The company completed a rights issue on May 7, 2025, issuing 368,071,365 shares at a subscription price of HKD 0.11 per share, raising approximately HKD 39,900,000 net of expenses[59] - The company acquired 100% equity of a target company on November 11, 2025, with a total consideration of HKD 48,510,000 paid through the issuance of 147,000,000 shares at a price of HKD 0.33 per share[61] Employee and Operational Costs - Total employee costs decreased to HKD 6,763,000 in 2025 from HKD 11,991,000 in 2024, reflecting a reduction in wages and benefits[21] - Administrative expenses decreased by approximately 32.5% to about HKD 16,400,000 for the year ended December 31, 2025, down from approximately HKD 24,200,000 for the year ended December 31, 2024, mainly due to reduced employee costs[51] - Sales and distribution costs for the year ended December 31, 2025, increased by approximately 528.7% to about HKD 3,500,000 from approximately HKD 600,000 for the year ended December 31, 2024, primarily due to increased fees and service charges from e-commerce platforms[51] Impairment and Credit Losses - The impairment loss on financial assets totaled HKD 61,843,000 in 2025, significantly higher than HKD 4,550,000 in 2024[21] - The expected credit loss and impairment loss for receivables and interest amounted to approximately HKD 36,100,000 and HKD 8,000,000, respectively, for the year ending December 31, 2025[48] - The company recognized an impairment loss provision of approximately HKD 3,600,000 for an investment in an associate company for the year ended December 31, 2025[52] Market and Business Outlook - The company aims to expand its business footprint in mainland China and enhance its KOL network, driven by the strong demand for MCN services[49] - The board anticipates that the future performance of listed investments will be volatile and influenced by overall economic conditions and market sentiment[64] - The company plans to utilize the remaining unutilized proceeds from its public offering for various purposes, including the establishment and operation of regulated activities under the Securities and Futures Ordinance[55] Dividends and Shareholder Returns - The company did not declare any dividends for the year 2025, consistent with 2024[26] - The company does not recommend the payment of dividends for the year ended December 31, 2025, consistent with the previous year[53]
BFB HEALTH(00205) - 2025 - 年度业绩